Feng Feng

Feng Feng

Auto-generated profile, based on publicly available information

Feng Feng

Department of Medicine, Lillehei Heart Institute, University of Minnesota, Minneapolis (A.X., G.-J.K., H.L., E.J.K., F.F., S.C.D.).

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2021 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MLMan Liu
Man Liu
HLHong Liu
Hong Liu
PPPreethy Parthiban
Preethy Parthiban
GKGyeoung-Jin Kang
Gyeoung-Jin Kang
GSGuangbin Shi
Guangbin Shi
Samuel C. DudleySamuel C. Dudley
Samuel C. Dudley
Ischemic cardiomyopathy is associated with an increased risk of sudden death, activation of the unfolded protein response (UPR), and reductions in multiple cardiac ion channels. When activated, the protein kinase–like ER kinase (PERK) branch of the UPR reduces protein translation and abundance. We hypothesized that PERK inhibition could prevent ion channel downregulation and reduce arrhythmia risk after myocardial infarct (MI). MI induced in mice by coronary artery ligation resulted in reduced ion channel levels, ventricular tachycardia (VT), and prolonged corrected intervals between the Q and T waves on the ECGs (QTc). Protein levels of major cardiac ion channels were decreased. MI cardiomyocytes showed significantly prolonged action potential duration and decreased maximum upstroke velocity. Cardiac-specific PERK KO reduced electrical remodeling in response to MI, with shortened QTc intervals, fewer VT episodes, and higher survival rates. Pharmacological PERK inhibition had similar effects. In conclusion, we found that activated PERK during MI contributed to arrhythmia risk by the downregulation of select cardiac ion channels. PERK inhibition prevented these changes and reduced arrhythmia risk. These results suggest that ion channel downregulation during MI is a fundamental arrhythmia mechanism and that maintenance of ion channel levels is antiarrhythmic.

18 June 2024 in JCI Insight
Verified
Journal Article
Open access
PDF file
XZXiaoxu Zhou
Xiaoxu Zhou
HLHong Liu
Hong Liu
FFFeng Feng
Feng Feng
GKGyeoung-Jin Kang
Gyeoung-Jin Kang
MLMan Liu
Man Liu
Samuel C. DudleySamuel C. Dudley
Samuel C. Dudley
Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation (AF). The mechanisms underlying DM-associated AF are unclear. AF and DM are both related to inflammation. We investigated whether DM-associated inflammation contributed to AF risk. Mice were fed with high-fat diet to induce type II DM and were subjected to IL-1β antibodies, macrophage depletion by clodronate liposomes, a mitochondrial antioxidant (mitoTEMPO), or a cardiac ryanodine receptor 2 (RyR2) stabilizer (S107). All tests were performed at 36–38 weeks of age. DM mice presented with increased AF inducibility, enhanced mitochondrial reactive oxygen species (mitoROS) generation, and activated innate immunity in the atria, as evidenced by enhanced monocyte chemoattractant protein-1 (MCP-1) expression, macrophage infiltration, and IL-1β levels. Signs of aberrant RyR2 Ca 2+ leak were observed in the atria of DM mice. IL-1β neutralization, macrophage depletion, and exposure to mitoTEMPO and S107 significantly ameliorated the AF vulnerability in DM mice. Atrial overexpression of MCP-1 increased AF occurrence in normal mice through the same mechanistic signaling cascade as observed in DM mice. In conclusion, macrophage-mediated IL-1β contributed to DM-associated AF risk through mitoROS modulation of RyR2 Ca 2+ leak.

1 October 2024 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Open access
AXAn Xie
An Xie
GKGyeoung-Jin Kang
Gyeoung-Jin Kang
EKEunji KIM
Eunji KIM
HLHong Liu
Hong Liu
FFFeng Feng
Feng Feng
Samuel C. DudleySamuel C. Dudley
Samuel C. Dudley
BACKGROUND: Increased mitochondrial Ca 2+ uptake has been implicated in the QT prolongation and lethal arrhythmias associated with nonischemic cardiomyopathy. We attempted to define the role of mitochondria in ischemic arrhythmic risk and to identify upstream regulators. METHODS: Myocardial infarction (MI) was induced in wild-type FVB/NJ mice by ligation of the left anterior descending coronary artery. Western blot, immunoprecipitation, ECG telemetry, and patch-clamp techniques were used. RESULTS: After MI, c-Src (proto-oncogene tyrosine-protein kinase Src) and its active form (phosphorylated Src, p-Src) were increased. The activation of c-Src was associated with increased diastolic Ca 2+ sparks, action potential duration prolongation, and arrhythmia in MI mice. c-Src upregulation and arrhythmia could be reversed by treatment of mice with the Src inhibitor PP1 but not with the inactive analogue PP3. Tyrosine phosphorylated mitochondrial Ca 2+ uniporter (MCU) was upregulated in the heart tissues of MI mice and patients with ischemic cardiomyopathy. In a heterologous expression system, c-Src could bind MCU and phosphorylate MCU tyrosines. Overexpression of wild-type c-Src significantly increased the mitochondrial Ca 2+ transient while overexpression of dominant-negative c-Src significantly decreased the mitochondrial Ca 2+ transient. c-Src inhibition by PP1, MCU inhibition by Ru360, or MCU knockdown could reduce the action potential duration, Ca 2+ sparks, and arrhythmia after MI. The human heart tissue showed that patients with ischemic cardiomyopathy had significantly increased c-Src active form associated with increased MCU tyrosine phosphorylation and ventricular arrhythmia. CONCLUSIONS: MI leads to increased c-Src active form that results in MCU tyrosine phosphorylation, increased mitochondrial Ca 2+ uptake, QT prolongation, and arrhythmia, suggesting c-Src or MCU may represent novel antiarrhythmic targets.

24 October 2025 in Circulation Research
Verified
Journal Article
Closed access
SPShanmugasundaram Pakkiriswami
Shanmugasundaram Pakkiriswami
JSJae Hwi Sung
Jae Hwi Sung
KSKshama R. Shah
Kshama R. Shah
UÖUlaş Özkurede
Ulaş Özkurede
MSMegan K. Sumera
Megan K. Sumera
JLJulia C. Liu
Julia C. Liu
BACKGROUND: Mitochondrial ATP production, essential for cardiomyocyte function, is regulated by mitochondrial Ca 2+ (mtCa 2+ ). The primary route for mtCa 2+ influx is the mitochondrial calcium uniporter complex. The mitochondrial calcium uniporter complex subunit MICU (mitochondrial calcium uptake) 1 limits mtCa 2+ uptake, preventing mtCa 2+ overload. Although elevated mtCa 2+ has been observed in multiple diseases including heart failure, its effects on heart function remain elusive. METHODS: To investigate the impact of elevated mtCa 2+ in adult hearts, we generated a mouse model with cardiomyocyte-specific tamoxifen-inducible Micu1 deletion ( Micu1 cKO ). Cardiac function was assessed through echocardiography. Mitochondria, adult cardiomyocytes, and tissue extracts were isolated from the left ventricle (LV) and right ventricle (RV) for comprehensive analysis at multiple time points ranging from 1 to 9 weeks post-tamoxifen injection. RESULTS: Acute MICU1 deficiency resulted in increased mtCa 2+ accompanied by reduced mitochondrial respiration in both the RV and LV. Contractile function, which was diminished in both ventricles initially, remained reduced in the RV upon prolonged MICU1 deficiency. In contrast, the LV exhibited signs of recovery over time, including restored ejection fraction concurrent with normalization of mtCa 2+ levels. This pattern was mirrored in cardiomyocyte contractility. In Micu1 cKO RV, mtCa 2+ remained elevated, likely contributing to oxidative stress. As a potential mechanism underlying LV-specific recovery, EMRE (essential MCU [mitochondrial calcium uniporter] regulator), an mitochondrial calcium uniporter complex subunit that promotes mtCa 2+ uptake, was found to be downregulated only in the LV. This suggested that the LV initiated a compensatory response to elevated mtCa 2+ , while the RV remained impacted. Supporting this, proteomics analysis indicated a divergent proteomic signature in Micu1 cKO RV. Follow-up experiments suggested enhanced EMRE degradation in Micu1 cKO LV mediated by m-AAA proteases through a PKA (protein kinase A)–regulated mechanism. In MICU1-deficient neonatal cardiomyocytes, pharmacological PKA inhibition was sufficient to decrease EMRE levels. Analysis of LV tissues from patients with dilated cardiomyopathy suggested that this pathway may be relevant in human DCM. CONCLUSIONS: While elevated mtCa 2+ disrupted cardiac function in both ventricles, it induced an LV-specific adaptive response that suppressed mtCa 2+ intake, contributing to the recovery of mitochondrial and cardiac function. The absence of this pathway in the RV has implications for therapeutics targeting RV dysfunction, a key determinant of mortality in heart failure.

1 November 2025 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Open access
AXAn Xie
An Xie
GKGyeoung-Jin Kang
Gyeoung-Jin Kang
HLHong Liu
Hong Liu
EKEunji KIM
Eunji KIM
FFFeng Feng
Feng Feng
Samuel C. DudleySamuel C. Dudley
Samuel C. Dudley
BACKGROUND: In nonischemic cardiomyopathy, mitochondrial Ca 2+ handling is involved in arrhythmogenesis by modulating diastolic sarcoplasmic reticulum (SR) Ca 2+ release. Recently, it has been reported that lysosomal Ca 2+ release can trigger an SR Ca 2+ release. We investigated whether lysosomal Ca 2+ flux through the TRPML1 (transient receptor potential mucolipin 1) channel could contribute to ischemic cardiomyopathy-related arrhythmia by causing diastolic SR Ca 2+ release. METHODS: Ischemic cardiomyopathy was induced in wild-type C57BL/6J and TRPML1 heterozygous knockdown (TRPML1±) mice by ligating the left anterior descending coronary artery. Mice were studied at 3 weeks after myocardial infarction (MI). RESULTS: After MI, the lysosomal-restricted TRPML1 Ca 2+ release channel was significantly increased in human patients with ischemic or nonischemic cardiomyopathy. TRPML1, but not the TPC2 (2-pore channel 2), was significantly upregulated by 85% in the mouse MI border zone and by 55% in a remote zone. Lysosomal number and approximation to the SR were increased after MI. Lysosomal Ca 2+ release was substantially upregulated in MI mouse cardiomyocytes compared with sham cardiomyocytes. The action potential duration was prolonged, and arrhythmogenic diastolic SR Ca 2+ release was increased in the cardiomyocytes isolated from MI mice. Blocking TRPML1 reduced action potential duration prolongation and depressed early and delayed afterdepolarizations in cardiomyocytes isolated from MI mice, while the TRPML1 agonist increased TRPML1-dependent cellular triggered activity. A TRPML1 antagonist could inhibit induced ventricular fibrillation in MI mice. Consistent with that result, genetic knockdown of TRPML1 could inhibit arrhythmic risk after MI. The effects of TRPML1-targeted drugs were not seen in control cardiomyocytes. CONCLUSIONS: Lysosomes contribute to arrhythmic risk after MI because of increased number, proximity to the SR, and induction of diastolic SR Ca 2+ release mediated by TRPML1-dependent lysosomal Ca 2+ release.